← Back to Overview
Prostate Screening in Indonesia: PSA Testing & BPJS Access
When to initiate screening, interpreting PSA test results, and navigating the Indonesian BPJS referral pathway for urology care.
Clinical Utility of PSA Testing
Prostate-Specific Antigen (PSA) is a glycoprotein enzyme produced by prostatic epithelial cells. While commonly utilized in screening, serum PSA elevation can occur due to benign prostatic hyperplasia (BPH), prostatitis, recent ejaculation, or vigorous cycling — and does not indicate malignancy in isolation.
Screening Timelines
- Age 40+: Men with first-degree family history of prostatic pathology should discuss baseline PSA assessment with their physician.
- Age 45–50+: General population baseline screening discussion as part of annual health evaluations.
- Any age: Immediate clinical evaluation for hematuria (blood in urine), hematospermia, acute urinary retention, or fever with dysuria.
Navigating BPJS Healthcare in Indonesia
- Present to your assigned Faskes Tingkat 1 (Puskesmas or registered Klinik Pratama).
- Consult with the general practitioner regarding specific urological symptoms to obtain a Surat Rujukan.
- Schedule an outpatient appointment at the referred secondary hospital's Poliklinik Urologi.
⚕️ Disclaimer
Educational overview of Indonesian healthcare procedures. Never delay seeking urgent medical care based on online content.